Intrarenal pressure and exaggerated natriuresis in essential hypertension

Clinical Science
J LowensteinD S Baldwin

Abstract

No abstract listed.

Citations

Oct 1, 1977·Scandinavian Journal of Clinical and Laboratory Investigation·C E Mogensen, Sølling
Jan 1, 1987·Clinical and Experimental Hypertension. Part A, Theory and Practice·C Bell
Jan 1, 1985·Clinical and Experimental Hypertension. Part A, Theory and Practice·J F Slegers, W M Moons
Jan 1, 1984·Clinical and Experimental Hypertension. Part A, Theory and Practice·T KokubuH Hashimoto
Jan 1, 1981·Clinical and Experimental Hypertension : CHE·G A MacGregor, H E de Wardener
Jan 1, 1981·Clinical and Experimental Hypertension : CHE·M LebelR Blais
Jan 1, 1982·Clinical and Experimental Hypertension. Part A, Theory and Practice·M Mendlowitz
Apr 1, 1993·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·H C LeeW A Pettinger
May 1, 1993·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·V M CampeseR Bigazzi
Apr 1, 1985·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·D S Baldwin, J Neugarten
Aug 1, 1982·Kidney International·D E Oken
Nov 1, 1980·Kidney International·M A Weber, J I Drayer
Jun 1, 1978·Kidney International·G W ThomasK M Yeates
Sep 1, 1984·Kidney International·G M LondonM E Safar
Oct 13, 2010·Cardiology Clinics·Mukesh SinghGeorge Bakris
Dec 10, 1999·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·S BianchiV M Campese
Jul 31, 2004·Acta Physiologica Scandinavica·K Skov, M J Mulvany
Oct 1, 1993·Metabolism: Clinical and Experimental·P CoruzziA Novarini
Jan 1, 1979·Journal of Chronic Diseases·R G SchachtD S Baldwin
Jul 1, 1982·Acta Physiologica Scandinavica·S LundinG Berglund
Sep 1, 1985·British Journal of Clinical Pharmacology·I G MackayM L Watson
Feb 1, 1983·European Journal of Clinical Investigation·M RathausJ Bernheim
Feb 1, 1981·The American Journal of Medicine·J LowensteinD S Baldwin
Aug 16, 2016·Frontiers in Physiology·Holly Digne-MalcolmKeith L Dorrington
Mar 31, 2005·American Journal of Hypertension·Richard J JohnsonJaime Herrera-Acosta
Nov 11, 1975·Clinical and Experimental Pharmacology & Physiology·T G ColemanR D Manning
Jul 11, 2003·Cardiology in Review·John KanellisRichard J Johnson
Dec 1, 1978·European Journal of Clinical Pharmacology·F AndreasenE Mikkelsen
Jul 1, 1980·Hypertension·P OmvikE L Bravo
Aug 1, 1987·Hypertension·M E Safar, G M London
Nov 1, 1985·Hypertension·S BlakeT Walley
May 1, 1986·Hypertension·M EpsteinR Levinson
Apr 1, 1987·Hypertension·M T VelasquezA W Cowley

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.